Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-01 00:59:45 - browse：8

Layoff concept illustration of empty desks and people walking away. — Adobe

Dewpoint Therapeutics, the buzziest startup trying to tackle a new field of biology called biomolecular condensates, laid off 15% of its staff on Tuesday and acknowledged that a pair of collaboration deals with pharma companies had fallen apart.

The downsizing is temporary, CEO Ameet Nathwani told STAT. The company needed to hire new employees with expertise to help move the company’s first drugs into clinical trials and expand its AI capabilities. And with funding for early-stage biotechs still sparse, leadership opted to cut some positions and use the savings to fill new ones over the coming months. Roughly 20 positions were cut.

“We talked to investors right now [about raising more money], and they think that the environment for a preclinical company — it’s not even worth having that discussion,” Nathwani said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Schizophrenia gene found to be linked to cells' energy dysfunction

WSS

Bernie brings in new pharma CEOs to talk drug prices

Texas Medical Board asked to define abortion emergency exception

Problems with a popular proposal to regulate AI in health care

A single Democrat is willing to weaken Medicare negotiation power

What’s missing from the debate over nursing home staff minimums

Texas Medical Board asked to define abortion emergency exception

hotspot

Wikipedia

hotspot

Guidelines to prevent youth baseball injuries need more muscle

Biogen’s boardroom scandal saddles CEO with first crisis

Peter Hotez and the public health issue of online harassment

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

In Memoriam: Notable people who died in 2023

Bird flu researchers hone in on Finland’s mink farms

State Dept. review finds Biden bears some blame for Afghanistan failures

Global cancer cases to surge 77% by 2050, WHO report says

Supreme Court strikes down use of affirmative action

Timeline: How the deadly wildfires took over Maui day by day

knowledge

Megan Rapinoe shares emotional post following US Women's World Cup exit

Top private equity targets in 2023: cardiology, clinical trials, lasers

The Biogen Aduhelm mess could happen again

Why Novartis is going to walk from its acquisition of MorphoSys

BMS, looking to build heart drug business, turns to AI for diagnosis

Updated Covid vaccine has 54% effectiveness, new study suggests

hotspot

focus

focus

entertainment